nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—Stiffness—Telbivudine—hepatitis B	0.0145	0.0249	CcSEcCtD
Irbesartan—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.0142	0.0244	CcSEcCtD
Irbesartan—Muscle atrophy—Lamivudine—hepatitis B	0.0132	0.0227	CcSEcCtD
Irbesartan—Localised oedema—Lamivudine—hepatitis B	0.0123	0.0211	CcSEcCtD
Irbesartan—Myositis—Telbivudine—hepatitis B	0.0113	0.0193	CcSEcCtD
Irbesartan—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0105	0.018	CcSEcCtD
Irbesartan—Glycosuria—Entecavir—hepatitis B	0.00829	0.0142	CcSEcCtD
Irbesartan—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00809	0.0139	CcSEcCtD
Irbesartan—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00802	0.0138	CcSEcCtD
Irbesartan—AGTR1—blood plasma—hepatitis B	0.00798	0.133	CbGeAlD
Irbesartan—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00684	0.0118	CcSEcCtD
Irbesartan—Raised liver function tests—Lamivudine—hepatitis B	0.00674	0.0116	CcSEcCtD
Irbesartan—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00644	0.0111	CcSEcCtD
Irbesartan—Tenderness—Telbivudine—hepatitis B	0.00633	0.0109	CcSEcCtD
Irbesartan—Rhabdomyolysis—Telbivudine—hepatitis B	0.00624	0.0107	CcSEcCtD
Irbesartan—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00615	0.0106	CcSEcCtD
Irbesartan—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00592	0.0102	CcSEcCtD
Irbesartan—Musculoskeletal pain—Telbivudine—hepatitis B	0.00559	0.00959	CcSEcCtD
Irbesartan—Hepatic function abnormal—Adefovir Dipivoxil—hepatitis B	0.00544	0.00935	CcSEcCtD
Irbesartan—UGT1A3—liver—hepatitis B	0.00536	0.0893	CbGeAlD
Irbesartan—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.005	0.00859	CcSEcCtD
Irbesartan—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00452	0.00776	CcSEcCtD
Irbesartan—Abdominal pain upper—Entecavir—hepatitis B	0.00445	0.00765	CcSEcCtD
Irbesartan—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00439	0.00754	CcSEcCtD
Irbesartan—CYP2C8—blood plasma—hepatitis B	0.00432	0.072	CbGeAlD
Irbesartan—Renal impairment—Telbivudine—hepatitis B	0.00421	0.00723	CcSEcCtD
Irbesartan—Pancreatitis—Entecavir—hepatitis B	0.00413	0.0071	CcSEcCtD
Irbesartan—CYP1A2—blood plasma—hepatitis B	0.00405	0.0674	CbGeAlD
Irbesartan—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00403	0.00692	CcSEcCtD
Irbesartan—Neutropenia—Entecavir—hepatitis B	0.00394	0.00677	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Entecavir—hepatitis B	0.00392	0.00673	CcSEcCtD
Irbesartan—JUN—blood—hepatitis B	0.00388	0.0646	CbGeAlD
Irbesartan—CYP2C9—blood plasma—hepatitis B	0.00384	0.064	CbGeAlD
Irbesartan—Hyperglycaemia—Entecavir—hepatitis B	0.0038	0.00653	CcSEcCtD
Irbesartan—Renal failure—Entecavir—hepatitis B	0.00369	0.00634	CcSEcCtD
Irbesartan—Abdominal pain upper—Telbivudine—hepatitis B	0.00366	0.00628	CcSEcCtD
Irbesartan—Cramp muscle—Telbivudine—hepatitis B	0.00361	0.0062	CcSEcCtD
Irbesartan—Renal failure—Adefovir Dipivoxil—hepatitis B	0.0036	0.00619	CcSEcCtD
Irbesartan—Nasopharyngitis—Telbivudine—hepatitis B	0.00358	0.00615	CcSEcCtD
Irbesartan—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00357	0.00614	CcSEcCtD
Irbesartan—Hepatobiliary disease—Entecavir—hepatitis B	0.00355	0.0061	CcSEcCtD
Irbesartan—Muscular weakness—Telbivudine—hepatitis B	0.00353	0.00607	CcSEcCtD
Irbesartan—Rhabdomyolysis—Lamivudine—hepatitis B	0.00352	0.00604	CcSEcCtD
Irbesartan—PTGS1—blood plasma—hepatitis B	0.00351	0.0584	CbGeAlD
Irbesartan—Abdominal distension—Telbivudine—hepatitis B	0.00349	0.00599	CcSEcCtD
Irbesartan—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00347	0.00596	CcSEcCtD
Irbesartan—Influenza—Telbivudine—hepatitis B	0.00346	0.00595	CcSEcCtD
Irbesartan—Hepatitis—Entecavir—hepatitis B	0.00337	0.00579	CcSEcCtD
Irbesartan—Drug interaction—Lamivudine—hepatitis B	0.00335	0.00576	CcSEcCtD
Irbesartan—Oedema peripheral—Entecavir—hepatitis B	0.00332	0.00571	CcSEcCtD
Irbesartan—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00329	0.00565	CcSEcCtD
Irbesartan—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00327	0.00561	CcSEcCtD
Irbesartan—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00325	0.00558	CcSEcCtD
Irbesartan—Neutropenia—Telbivudine—hepatitis B	0.00324	0.00556	CcSEcCtD
Irbesartan—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00323	0.00555	CcSEcCtD
Irbesartan—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00323	0.00554	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00322	0.00553	CcSEcCtD
Irbesartan—Vasculitis—Lamivudine—hepatitis B	0.00319	0.00547	CcSEcCtD
Irbesartan—Musculoskeletal pain—Lamivudine—hepatitis B	0.00315	0.00541	CcSEcCtD
Irbesartan—Immune system disorder—Entecavir—hepatitis B	0.00305	0.00523	CcSEcCtD
Irbesartan—Renal failure—Telbivudine—hepatitis B	0.00304	0.00521	CcSEcCtD
Irbesartan—JUN—liver—hepatitis B	0.00303	0.0506	CbGeAlD
Irbesartan—Wheezing—Lamivudine—hepatitis B	0.00302	0.00519	CcSEcCtD
Irbesartan—Malnutrition—Entecavir—hepatitis B	0.00294	0.00504	CcSEcCtD
Irbesartan—CYP3A4—blood plasma—hepatitis B	0.00293	0.0488	CbGeAlD
Irbesartan—AGTR1—blood—hepatitis B	0.00292	0.0487	CbGeAlD
Irbesartan—Aplastic anaemia—Lamivudine—hepatitis B	0.00292	0.00501	CcSEcCtD
Irbesartan—Hepatobiliary disease—Telbivudine—hepatitis B	0.00292	0.00501	CcSEcCtD
Irbesartan—CYP2D6—blood plasma—hepatitis B	0.00288	0.048	CbGeAlD
Irbesartan—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00287	0.00492	CcSEcCtD
Irbesartan—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00282	0.00485	CcSEcCtD
Irbesartan—Hepatitis—Telbivudine—hepatitis B	0.00277	0.00476	CcSEcCtD
Irbesartan—Hypoaesthesia—Telbivudine—hepatitis B	0.00276	0.00474	CcSEcCtD
Irbesartan—Pharyngitis—Telbivudine—hepatitis B	0.00275	0.00472	CcSEcCtD
Irbesartan—Connective tissue disorder—Telbivudine—hepatitis B	0.00272	0.00468	CcSEcCtD
Irbesartan—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00265	0.00455	CcSEcCtD
Irbesartan—Leukopenia—Entecavir—hepatitis B	0.00263	0.00451	CcSEcCtD
Irbesartan—Sleep disorder—Lamivudine—hepatitis B	0.00261	0.00448	CcSEcCtD
Irbesartan—Gastroenteritis—Lamivudine—hepatitis B	0.00255	0.00437	CcSEcCtD
Irbesartan—Cough—Adefovir Dipivoxil—hepatitis B	0.0025	0.00429	CcSEcCtD
Irbesartan—Mediastinal disorder—Telbivudine—hepatitis B	0.0025	0.00429	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00248	0.00426	CcSEcCtD
Irbesartan—Injury—Lamivudine—hepatitis B	0.00246	0.00422	CcSEcCtD
Irbesartan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00244	0.00419	CcSEcCtD
Irbesartan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00244	0.00419	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00242	0.00416	CcSEcCtD
Irbesartan—Malnutrition—Telbivudine—hepatitis B	0.00241	0.00414	CcSEcCtD
Irbesartan—Anaphylactic shock—Entecavir—hepatitis B	0.0024	0.00412	CcSEcCtD
Irbesartan—Infection—Entecavir—hepatitis B	0.00238	0.00409	CcSEcCtD
Irbesartan—Renal impairment—Lamivudine—hepatitis B	0.00237	0.00407	CcSEcCtD
Irbesartan—Dysgeusia—Telbivudine—hepatitis B	0.00236	0.00406	CcSEcCtD
Irbesartan—Nervous system disorder—Entecavir—hepatitis B	0.00235	0.00404	CcSEcCtD
Irbesartan—Skin disorder—Entecavir—hepatitis B	0.00233	0.004	CcSEcCtD
Irbesartan—Muscle spasms—Telbivudine—hepatitis B	0.00232	0.00398	CcSEcCtD
Irbesartan—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00229	0.00394	CcSEcCtD
Irbesartan—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00229	0.00393	CcSEcCtD
Irbesartan—AGTR1—liver—hepatitis B	0.00229	0.0381	CbGeAlD
Irbesartan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00227	0.0039	CcSEcCtD
Irbesartan—Ill-defined disorder—Telbivudine—hepatitis B	0.00224	0.00384	CcSEcCtD
Irbesartan—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00223	0.00383	CcSEcCtD
Irbesartan—Affect lability—Lamivudine—hepatitis B	0.00222	0.00382	CcSEcCtD
Irbesartan—Malaise—Telbivudine—hepatitis B	0.00218	0.00374	CcSEcCtD
Irbesartan—Mood swings—Lamivudine—hepatitis B	0.00214	0.00367	CcSEcCtD
Irbesartan—Somnolence—Entecavir—hepatitis B	0.00213	0.00366	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00213	0.00366	CcSEcCtD
Irbesartan—Dyspepsia—Entecavir—hepatitis B	0.00211	0.00362	CcSEcCtD
Irbesartan—Cough—Telbivudine—hepatitis B	0.00211	0.00362	CcSEcCtD
Irbesartan—Liver function test abnormal—Lamivudine—hepatitis B	0.00208	0.00358	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Entecavir—hepatitis B	0.00207	0.00355	CcSEcCtD
Irbesartan—Fatigue—Entecavir—hepatitis B	0.00207	0.00355	CcSEcCtD
Irbesartan—Abdominal pain upper—Lamivudine—hepatitis B	0.00206	0.00354	CcSEcCtD
Irbesartan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00206	0.00354	CcSEcCtD
Irbesartan—Myalgia—Telbivudine—hepatitis B	0.00205	0.00353	CcSEcCtD
Irbesartan—Chest pain—Telbivudine—hepatitis B	0.00205	0.00353	CcSEcCtD
Irbesartan—Arthralgia—Telbivudine—hepatitis B	0.00205	0.00353	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00204	0.0035	CcSEcCtD
Irbesartan—Cramp muscle—Lamivudine—hepatitis B	0.00203	0.00349	CcSEcCtD
Irbesartan—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00203	0.00349	CcSEcCtD
Irbesartan—Discomfort—Telbivudine—hepatitis B	0.00203	0.00348	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00202	0.00347	CcSEcCtD
Irbesartan—Nasopharyngitis—Lamivudine—hepatitis B	0.00202	0.00347	CcSEcCtD
Irbesartan—Muscular weakness—Lamivudine—hepatitis B	0.00199	0.00342	CcSEcCtD
Irbesartan—Abdominal distension—Lamivudine—hepatitis B	0.00196	0.00337	CcSEcCtD
Irbesartan—Gastrointestinal pain—Entecavir—hepatitis B	0.00196	0.00337	CcSEcCtD
Irbesartan—Dysphagia—Lamivudine—hepatitis B	0.00195	0.00335	CcSEcCtD
Irbesartan—Influenza—Lamivudine—hepatitis B	0.00195	0.00335	CcSEcCtD
Irbesartan—Nervous system disorder—Telbivudine—hepatitis B	0.00193	0.00332	CcSEcCtD
Irbesartan—Thrombocytopenia—Telbivudine—hepatitis B	0.00193	0.00331	CcSEcCtD
Irbesartan—Pancreatitis—Lamivudine—hepatitis B	0.00191	0.00329	CcSEcCtD
Irbesartan—Skin disorder—Telbivudine—hepatitis B	0.00191	0.00328	CcSEcCtD
Irbesartan—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00191	0.00328	CcSEcCtD
Irbesartan—Abdominal pain—Entecavir—hepatitis B	0.00189	0.00325	CcSEcCtD
Irbesartan—Body temperature increased—Entecavir—hepatitis B	0.00189	0.00325	CcSEcCtD
Irbesartan—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00185	0.00317	CcSEcCtD
Irbesartan—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00185	0.00317	CcSEcCtD
Irbesartan—Neutropenia—Lamivudine—hepatitis B	0.00182	0.00313	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00179	0.00308	CcSEcCtD
Irbesartan—Paraesthesia—Telbivudine—hepatitis B	0.00177	0.00304	CcSEcCtD
Irbesartan—Hyperglycaemia—Lamivudine—hepatitis B	0.00176	0.00302	CcSEcCtD
Irbesartan—Dyspepsia—Telbivudine—hepatitis B	0.00173	0.00298	CcSEcCtD
Irbesartan—Valsartan—ALB—hepatitis B	0.00172	0.672	CrCbGaD
Irbesartan—Asthenia—Entecavir—hepatitis B	0.00172	0.00295	CcSEcCtD
Irbesartan—Renal failure—Lamivudine—hepatitis B	0.00171	0.00294	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0017	0.00292	CcSEcCtD
Irbesartan—Fatigue—Telbivudine—hepatitis B	0.0017	0.00292	CcSEcCtD
Irbesartan—Jaundice—Lamivudine—hepatitis B	0.0017	0.00291	CcSEcCtD
Irbesartan—Pain—Telbivudine—hepatitis B	0.00168	0.00289	CcSEcCtD
Irbesartan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00168	0.00288	CcSEcCtD
Irbesartan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00165	0.00284	CcSEcCtD
Irbesartan—Hepatobiliary disease—Lamivudine—hepatitis B	0.00165	0.00283	CcSEcCtD
Irbesartan—Epistaxis—Lamivudine—hepatitis B	0.00164	0.00282	CcSEcCtD
Irbesartan—Diarrhoea—Entecavir—hepatitis B	0.00164	0.00282	CcSEcCtD
Irbesartan—Agranulocytosis—Lamivudine—hepatitis B	0.00162	0.00279	CcSEcCtD
Irbesartan—Feeling abnormal—Telbivudine—hepatitis B	0.00162	0.00279	CcSEcCtD
Irbesartan—Gastrointestinal pain—Telbivudine—hepatitis B	0.00161	0.00276	CcSEcCtD
Irbesartan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0016	0.00275	CcSEcCtD
Irbesartan—Dizziness—Entecavir—hepatitis B	0.00159	0.00272	CcSEcCtD
Irbesartan—CYP2C8—blood—hepatitis B	0.00158	0.0264	CbGeAlD
Irbesartan—Rhinitis—Lamivudine—hepatitis B	0.00157	0.00269	CcSEcCtD
Irbesartan—Hepatitis—Lamivudine—hepatitis B	0.00156	0.00268	CcSEcCtD
Irbesartan—Abdominal pain—Telbivudine—hepatitis B	0.00156	0.00267	CcSEcCtD
Irbesartan—Body temperature increased—Telbivudine—hepatitis B	0.00156	0.00267	CcSEcCtD
Irbesartan—Hypoaesthesia—Lamivudine—hepatitis B	0.00155	0.00267	CcSEcCtD
Irbesartan—Pharyngitis—Lamivudine—hepatitis B	0.00155	0.00266	CcSEcCtD
Irbesartan—Connective tissue disorder—Lamivudine—hepatitis B	0.00153	0.00264	CcSEcCtD
Irbesartan—Vomiting—Entecavir—hepatitis B	0.00152	0.00262	CcSEcCtD
Irbesartan—Rash—Entecavir—hepatitis B	0.00151	0.0026	CcSEcCtD
Irbesartan—Dermatitis—Entecavir—hepatitis B	0.00151	0.00259	CcSEcCtD
Irbesartan—Headache—Entecavir—hepatitis B	0.0015	0.00258	CcSEcCtD
Irbesartan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00149	0.00255	CcSEcCtD
Irbesartan—CYP1A2—blood—hepatitis B	0.00148	0.0247	CbGeAlD
Irbesartan—Rash—Adefovir Dipivoxil—hepatitis B	0.00147	0.00253	CcSEcCtD
Irbesartan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00147	0.00253	CcSEcCtD
Irbesartan—Headache—Adefovir Dipivoxil—hepatitis B	0.00147	0.00252	CcSEcCtD
Irbesartan—Nausea—Entecavir—hepatitis B	0.00142	0.00244	CcSEcCtD
Irbesartan—Asthenia—Telbivudine—hepatitis B	0.00141	0.00243	CcSEcCtD
Irbesartan—Immune system disorder—Lamivudine—hepatitis B	0.00141	0.00242	CcSEcCtD
Irbesartan—Mediastinal disorder—Lamivudine—hepatitis B	0.00141	0.00242	CcSEcCtD
Irbesartan—CYP2C9—blood—hepatitis B	0.00141	0.0234	CbGeAlD
Irbesartan—Chills—Lamivudine—hepatitis B	0.0014	0.00241	CcSEcCtD
Irbesartan—Pruritus—Telbivudine—hepatitis B	0.00139	0.00239	CcSEcCtD
Irbesartan—Nausea—Adefovir Dipivoxil—hepatitis B	0.00139	0.00239	CcSEcCtD
Irbesartan—Erythema—Lamivudine—hepatitis B	0.00136	0.00233	CcSEcCtD
Irbesartan—Malnutrition—Lamivudine—hepatitis B	0.00136	0.00233	CcSEcCtD
Irbesartan—Diarrhoea—Telbivudine—hepatitis B	0.00135	0.00231	CcSEcCtD
Irbesartan—Flatulence—Lamivudine—hepatitis B	0.00134	0.0023	CcSEcCtD
Irbesartan—Tension—Lamivudine—hepatitis B	0.00133	0.00229	CcSEcCtD
Irbesartan—Dysgeusia—Lamivudine—hepatitis B	0.00133	0.00229	CcSEcCtD
Irbesartan—Nervousness—Lamivudine—hepatitis B	0.00132	0.00227	CcSEcCtD
Irbesartan—Muscle spasms—Lamivudine—hepatitis B	0.00131	0.00224	CcSEcCtD
Irbesartan—Dizziness—Telbivudine—hepatitis B	0.0013	0.00224	CcSEcCtD
Irbesartan—PTGS1—blood—hepatitis B	0.00128	0.0214	CbGeAlD
Irbesartan—Tremor—Lamivudine—hepatitis B	0.00127	0.00219	CcSEcCtD
Irbesartan—Ill-defined disorder—Lamivudine—hepatitis B	0.00126	0.00217	CcSEcCtD
Irbesartan—Anaemia—Lamivudine—hepatitis B	0.00126	0.00216	CcSEcCtD
Irbesartan—Vomiting—Telbivudine—hepatitis B	0.00125	0.00215	CcSEcCtD
Irbesartan—Angioedema—Lamivudine—hepatitis B	0.00124	0.00213	CcSEcCtD
Irbesartan—Rash—Telbivudine—hepatitis B	0.00124	0.00213	CcSEcCtD
Irbesartan—Dermatitis—Telbivudine—hepatitis B	0.00124	0.00213	CcSEcCtD
Irbesartan—CYP2C8—liver—hepatitis B	0.00124	0.0206	CbGeAlD
Irbesartan—Headache—Telbivudine—hepatitis B	0.00123	0.00212	CcSEcCtD
Irbesartan—Malaise—Lamivudine—hepatitis B	0.00123	0.00211	CcSEcCtD
Irbesartan—Vertigo—Lamivudine—hepatitis B	0.00122	0.0021	CcSEcCtD
Irbesartan—Syncope—Lamivudine—hepatitis B	0.00122	0.00209	CcSEcCtD
Irbesartan—Leukopenia—Lamivudine—hepatitis B	0.00122	0.00209	CcSEcCtD
Irbesartan—Loss of consciousness—Lamivudine—hepatitis B	0.0012	0.00205	CcSEcCtD
Irbesartan—Cough—Lamivudine—hepatitis B	0.00119	0.00204	CcSEcCtD
Irbesartan—Nausea—Telbivudine—hepatitis B	0.00117	0.00201	CcSEcCtD
Irbesartan—CYP1A2—liver—hepatitis B	0.00116	0.0193	CbGeAlD
Irbesartan—Chest pain—Lamivudine—hepatitis B	0.00116	0.00199	CcSEcCtD
Irbesartan—Myalgia—Lamivudine—hepatitis B	0.00116	0.00199	CcSEcCtD
Irbesartan—Arthralgia—Lamivudine—hepatitis B	0.00116	0.00199	CcSEcCtD
Irbesartan—Anxiety—Lamivudine—hepatitis B	0.00115	0.00198	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00115	0.00197	CcSEcCtD
Irbesartan—Discomfort—Lamivudine—hepatitis B	0.00114	0.00196	CcSEcCtD
Irbesartan—Dry mouth—Lamivudine—hepatitis B	0.00113	0.00194	CcSEcCtD
Irbesartan—Oedema—Lamivudine—hepatitis B	0.00111	0.00191	CcSEcCtD
Irbesartan—Anaphylactic shock—Lamivudine—hepatitis B	0.00111	0.00191	CcSEcCtD
Irbesartan—Infection—Lamivudine—hepatitis B	0.0011	0.00189	CcSEcCtD
Irbesartan—CYP2C9—liver—hepatitis B	0.0011	0.0183	CbGeAlD
Irbesartan—Shock—Lamivudine—hepatitis B	0.00109	0.00187	CcSEcCtD
Irbesartan—Nervous system disorder—Lamivudine—hepatitis B	0.00109	0.00187	CcSEcCtD
Irbesartan—Thrombocytopenia—Lamivudine—hepatitis B	0.00109	0.00187	CcSEcCtD
Irbesartan—Skin disorder—Lamivudine—hepatitis B	0.00108	0.00185	CcSEcCtD
Irbesartan—CYP3A4—blood—hepatitis B	0.00107	0.0179	CbGeAlD
Irbesartan—Hyperhidrosis—Lamivudine—hepatitis B	0.00107	0.00184	CcSEcCtD
Irbesartan—Anorexia—Lamivudine—hepatitis B	0.00106	0.00182	CcSEcCtD
Irbesartan—CYP2D6—blood—hepatitis B	0.00106	0.0176	CbGeAlD
Irbesartan—Hypotension—Lamivudine—hepatitis B	0.00104	0.00178	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00101	0.00174	CcSEcCtD
Irbesartan—Paraesthesia—Lamivudine—hepatitis B	0.000997	0.00171	CcSEcCtD
Irbesartan—Dyspnoea—Lamivudine—hepatitis B	0.000989	0.0017	CcSEcCtD
Irbesartan—Somnolence—Lamivudine—hepatitis B	0.000987	0.00169	CcSEcCtD
Irbesartan—Dyspepsia—Lamivudine—hepatitis B	0.000977	0.00168	CcSEcCtD
Irbesartan—Decreased appetite—Lamivudine—hepatitis B	0.000965	0.00166	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000958	0.00165	CcSEcCtD
Irbesartan—Fatigue—Lamivudine—hepatitis B	0.000957	0.00164	CcSEcCtD
Irbesartan—Pain—Lamivudine—hepatitis B	0.000949	0.00163	CcSEcCtD
Irbesartan—Constipation—Lamivudine—hepatitis B	0.000949	0.00163	CcSEcCtD
Irbesartan—Feeling abnormal—Lamivudine—hepatitis B	0.000915	0.00157	CcSEcCtD
Irbesartan—Gastrointestinal pain—Lamivudine—hepatitis B	0.000907	0.00156	CcSEcCtD
Irbesartan—Urticaria—Lamivudine—hepatitis B	0.000882	0.00151	CcSEcCtD
Irbesartan—Abdominal pain—Lamivudine—hepatitis B	0.000877	0.00151	CcSEcCtD
Irbesartan—Body temperature increased—Lamivudine—hepatitis B	0.000877	0.00151	CcSEcCtD
Irbesartan—Losartan—ALB—hepatitis B	0.000842	0.328	CrCbGaD
Irbesartan—CYP3A4—liver—hepatitis B	0.000839	0.014	CbGeAlD
Irbesartan—CYP2D6—liver—hepatitis B	0.000826	0.0138	CbGeAlD
Irbesartan—Hypersensitivity—Lamivudine—hepatitis B	0.000818	0.0014	CcSEcCtD
Irbesartan—Asthenia—Lamivudine—hepatitis B	0.000796	0.00137	CcSEcCtD
Irbesartan—Pruritus—Lamivudine—hepatitis B	0.000785	0.00135	CcSEcCtD
Irbesartan—Diarrhoea—Lamivudine—hepatitis B	0.000759	0.0013	CcSEcCtD
Irbesartan—Dizziness—Lamivudine—hepatitis B	0.000734	0.00126	CcSEcCtD
Irbesartan—Vomiting—Lamivudine—hepatitis B	0.000706	0.00121	CcSEcCtD
Irbesartan—Rash—Lamivudine—hepatitis B	0.0007	0.0012	CcSEcCtD
Irbesartan—Dermatitis—Lamivudine—hepatitis B	0.000699	0.0012	CcSEcCtD
Irbesartan—Headache—Lamivudine—hepatitis B	0.000695	0.00119	CcSEcCtD
Irbesartan—Nausea—Lamivudine—hepatitis B	0.000659	0.00113	CcSEcCtD
Irbesartan—JUN—Immune System—PDCD1—hepatitis B	0.000289	0.000814	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN2A—hepatitis B	0.000289	0.000814	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKR1B1—hepatitis B	0.000289	0.000814	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RIT2—hepatitis B	0.000289	0.000813	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SAG—hepatitis B	0.000289	0.000813	CbGpPWpGaD
Irbesartan—JUN—BDNF signaling pathway—NFKB1—hepatitis B	0.000288	0.000811	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000286	0.000805	CbGpPWpGaD
Irbesartan—JUN—Apoptosis Modulation and Signaling—TP53—hepatitis B	0.000285	0.000803	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000283	0.000798	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000279	0.000785	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000278	0.000784	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000278	0.000784	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000277	0.00078	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT2—hepatitis B	0.000277	0.00078	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—IL6—hepatitis B	0.000275	0.000776	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—hepatitis B	0.000273	0.000769	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NFKB1—hepatitis B	0.000271	0.000764	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL10—hepatitis B	0.000271	0.000762	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00027	0.000761	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.00027	0.00076	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNGR1—hepatitis B	0.000269	0.000757	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—IL6—hepatitis B	0.000268	0.000755	CbGpPWpGaD
Irbesartan—JUN—Insulin Signaling—PTEN—hepatitis B	0.000266	0.000749	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—PTEN—hepatitis B	0.000263	0.000741	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL6—hepatitis B	0.000263	0.000741	CbGpPWpGaD
Irbesartan—JUN—Wnt Signaling Pathway and Pluripotency—TP53—hepatitis B	0.00026	0.000733	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—hepatitis B	0.000259	0.000728	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—IL6—hepatitis B	0.000259	0.000728	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFB1—hepatitis B	0.000257	0.000724	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—NFKB1—hepatitis B	0.000254	0.000717	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—hepatitis B	0.000254	0.000716	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TP53—hepatitis B	0.000254	0.000716	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR2—hepatitis B	0.000253	0.000712	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IFNB1—hepatitis B	0.000251	0.000707	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—F2—hepatitis B	0.00025	0.000704	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000248	0.000699	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—hepatitis B	0.000247	0.000695	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—hepatitis B	0.000247	0.000695	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.000246	0.000692	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL10—hepatitis B	0.000246	0.000692	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000245	0.000691	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IFNA1—hepatitis B	0.000245	0.00069	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000244	0.000687	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—IL6—hepatitis B	0.000244	0.000687	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00024	0.000676	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.000238	0.000671	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—CTNNB1—hepatitis B	0.000238	0.00067	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000237	0.000667	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CDKN1A—hepatitis B	0.000236	0.000665	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000236	0.000665	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—NFKB1—hepatitis B	0.000235	0.000661	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—hepatitis B	0.000233	0.000655	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.000233	0.000655	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000232	0.000653	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—PTEN—hepatitis B	0.000232	0.000653	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000231	0.000651	CbGpPWpGaD
Irbesartan—JUN—Immune System—MX1—hepatitis B	0.000231	0.000651	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000231	0.00065	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.00023	0.000649	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—hepatitis B	0.00023	0.000648	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.00023	0.000647	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000229	0.000645	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD14—hepatitis B	0.000228	0.000642	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IFNA2—hepatitis B	0.000228	0.000642	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000227	0.000639	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000226	0.000638	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000225	0.000633	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000224	0.00063	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—PTEN—hepatitis B	0.000221	0.000624	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—IL6—hepatitis B	0.000219	0.000618	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN2A—hepatitis B	0.000218	0.000615	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SAG—hepatitis B	0.000216	0.000607	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RIT2—hepatitis B	0.000216	0.000607	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL10—hepatitis B	0.000212	0.000598	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000212	0.000597	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—hepatitis B	0.000212	0.000596	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00021	0.000591	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CCR5—hepatitis B	0.00021	0.000591	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000206	0.000581	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—hepatitis B	0.000202	0.000569	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—hepatitis B	0.000198	0.000557	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000194	0.000546	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—hepatitis B	0.000193	0.000543	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000192	0.000541	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000192	0.00054	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000191	0.000539	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR5—hepatitis B	0.000191	0.000537	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.00019	0.000535	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000187	0.000528	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000187	0.000527	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000186	0.000523	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000184	0.000517	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—F2—hepatitis B	0.00018	0.000507	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000179	0.000503	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1A—hepatitis B	0.000178	0.000503	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—NFKB1—hepatitis B	0.000177	0.000499	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000175	0.000494	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000175	0.000493	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000175	0.000493	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—hepatitis B	0.000174	0.000491	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—hepatitis B	0.00017	0.00048	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000169	0.000477	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP2A6—hepatitis B	0.000168	0.000473	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000166	0.000467	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR5—hepatitis B	0.000165	0.000464	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000164	0.000462	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—F2—hepatitis B	0.000163	0.00046	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKR1B1—hepatitis B	0.000163	0.000458	CbGpPWpGaD
Irbesartan—JUN—Immune System—HSPA5—hepatitis B	0.000162	0.000456	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—hepatitis B	0.000161	0.000453	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000157	0.000443	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—hepatitis B	0.000156	0.00044	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT2—hepatitis B	0.000156	0.000439	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000153	0.000431	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DPB1—hepatitis B	0.000153	0.000431	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT2—hepatitis B	0.000152	0.000428	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—hepatitis B	0.000151	0.000426	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.00015	0.000421	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR5—hepatitis B	0.00015	0.000421	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR2—hepatitis B	0.000147	0.000415	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—hepatitis B	0.000147	0.000415	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNB1—hepatitis B	0.000146	0.000412	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—hepatitis B	0.000145	0.000409	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNA1—hepatitis B	0.000143	0.000402	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—F2—hepatitis B	0.000141	0.000398	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—hepatitis B	0.000138	0.00039	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD14—hepatitis B	0.000133	0.000374	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNA2—hepatitis B	0.000133	0.000374	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GGT1—hepatitis B	0.000131	0.000369	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GOT1—hepatitis B	0.000131	0.000369	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—F2—hepatitis B	0.000128	0.000361	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—hepatitis B	0.000122	0.000342	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—hepatitis B	0.000121	0.000341	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—hepatitis B	0.000114	0.000321	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—hepatitis B	0.000113	0.000319	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—hepatitis B	0.000113	0.000318	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—hepatitis B	0.000113	0.000317	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—hepatitis B	0.000112	0.000314	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—hepatitis B	0.000111	0.000313	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—hepatitis B	0.00011	0.00031	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—hepatitis B	0.00011	0.00031	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000107	0.000301	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKR1B1—hepatitis B	0.000105	0.000296	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT2—hepatitis B	0.000101	0.000284	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-A—hepatitis B	9.95e-05	0.00028	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTNNB1—hepatitis B	9.77e-05	0.000275	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—F2—hepatitis B	9.66e-05	0.000272	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1A—hepatitis B	9.55e-05	0.000269	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—PTEN—hepatitis B	9.53e-05	0.000268	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—hepatitis B	9.51e-05	0.000268	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKB1—hepatitis B	9.48e-05	0.000267	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2A6—hepatitis B	9.45e-05	0.000266	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—hepatitis B	9.1e-05	0.000256	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-DRB1—hepatitis B	9.09e-05	0.000256	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—hepatitis B	8.83e-05	0.000249	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	8.81e-05	0.000248	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.71e-05	0.000245	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—hepatitis B	8.64e-05	0.000243	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKR1B1—hepatitis B	8.63e-05	0.000243	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKR1B1—hepatitis B	8.56e-05	0.000241	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT2—hepatitis B	8.55e-05	0.000241	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—hepatitis B	8.51e-05	0.00024	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT2—hepatitis B	8.27e-05	0.000233	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT2—hepatitis B	8.2e-05	0.000231	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—F2—hepatitis B	7.58e-05	0.000213	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.44e-05	0.00021	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GGT1—hepatitis B	7.38e-05	0.000208	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GOT1—hepatitis B	7.38e-05	0.000208	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKR1B1—hepatitis B	7.31e-05	0.000206	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT2—hepatitis B	7.01e-05	0.000197	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ALB—hepatitis B	6.97e-05	0.000196	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.72e-05	0.000189	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—hepatitis B	6.64e-05	0.000187	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—hepatitis B	6.6e-05	0.000186	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—hepatitis B	6.5e-05	0.000183	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—hepatitis B	6.47e-05	0.000182	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—hepatitis B	6.41e-05	0.000181	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CTNNB1—hepatitis B	6.28e-05	0.000177	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1A—hepatitis B	6.13e-05	0.000173	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—PTEN—hepatitis B	6.12e-05	0.000172	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2A6—hepatitis B	6.11e-05	0.000172	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKB1—hepatitis B	6.09e-05	0.000172	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—hepatitis B	5.95e-05	0.000168	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—hepatitis B	5.9e-05	0.000166	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.69e-05	0.00016	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTNNB1—hepatitis B	5.69e-05	0.00016	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—F2—hepatitis B	5.66e-05	0.000159	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.64e-05	0.000159	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1A—hepatitis B	5.56e-05	0.000157	CbGpPWpGaD
Irbesartan—JUN—Immune System—PTEN—hepatitis B	5.55e-05	0.000156	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT2—hepatitis B	5.52e-05	0.000156	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKB1—hepatitis B	5.52e-05	0.000156	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT2—hepatitis B	5.41e-05	0.000152	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTEN—hepatitis B	5.32e-05	0.00015	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—hepatitis B	5.1e-05	0.000144	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—hepatitis B	5.08e-05	0.000143	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—hepatitis B	5.07e-05	0.000143	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2A6—hepatitis B	5.01e-05	0.000141	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.97e-05	0.00014	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CTNNB1—hepatitis B	4.93e-05	0.000139	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1A—hepatitis B	4.81e-05	0.000136	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PTEN—hepatitis B	4.8e-05	0.000135	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKB1—hepatitis B	4.78e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GGT1—hepatitis B	4.77e-05	0.000134	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GOT1—hepatitis B	4.77e-05	0.000134	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.63e-05	0.000131	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT2—hepatitis B	4.53e-05	0.000128	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT2—hepatitis B	4.49e-05	0.000127	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.34e-05	0.000122	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2A6—hepatitis B	4.25e-05	0.00012	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—hepatitis B	4.18e-05	0.000118	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—hepatitis B	3.98e-05	0.000112	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.96e-05	0.000112	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—hepatitis B	3.93e-05	0.000111	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—hepatitis B	3.91e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—hepatitis B	3.91e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—hepatitis B	3.88e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—hepatitis B	3.88e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—hepatitis B	3.84e-05	0.000108	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—hepatitis B	3.82e-05	0.000108	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—hepatitis B	3.81e-05	0.000107	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CTNNB1—hepatitis B	3.68e-05	0.000104	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1A—hepatitis B	3.6e-05	0.000101	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTEN—hepatitis B	3.59e-05	0.000101	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKB1—hepatitis B	3.57e-05	0.000101	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.54e-05	9.96e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—hepatitis B	3.47e-05	9.76e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—hepatitis B	3.32e-05	9.34e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—hepatitis B	3.32e-05	9.34e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.28e-05	9.23e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—hepatitis B	3.28e-05	9.23e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.02e-05	8.51e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—hepatitis B	3e-05	8.45e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTEN—hepatitis B	2.99e-05	8.44e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—hepatitis B	2.97e-05	8.38e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—hepatitis B	2.96e-05	8.35e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—hepatitis B	2.56e-05	7.21e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—hepatitis B	2.56e-05	7.21e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—hepatitis B	2.54e-05	7.14e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—hepatitis B	2.45e-05	6.9e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—hepatitis B	2.24e-05	6.31e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—hepatitis B	2.08e-05	5.86e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—hepatitis B	2.06e-05	5.81e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTEN—hepatitis B	1.93e-05	5.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—hepatitis B	1.76e-05	4.97e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTEN—hepatitis B	1.59e-05	4.47e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTEN—hepatitis B	1.57e-05	4.43e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—hepatitis B	1.36e-05	3.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTEN—hepatitis B	1.35e-05	3.79e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTEN—hepatitis B	1.04e-05	2.92e-05	CbGpPWpGaD
